Ключевые слова:
СБК, COVID-19, нефропатия, артериал гипертензия, хавф омиллариБиблиографические ссылки
Ахмедова Н. Ш. Лабораторные маркеры оценки функции почек при нефропатии разной этиологии // Тиббиётда янги кун. – 2022. – № 3 (41). – С. 56–59.
Бобкова И. Н., Шестакова М. В., Щукина А. А. Повреждение подоцитов при сахарном диабете // Сахарный диабет. – 2014. – Т. 17, № 3. – С. 39–50. – DOI: 10.14341/DM2014339-50.
Кобалава Ж. Д., Виллевалде С. В., Боровкова Н. Ю., Шутов А. М., Ничик Т. Е., Сафуанова Г. Ш. Распространённость маркеров хронической болезни почек у пациентов с артериальной гипертонией: результаты эпидемиологического исследования хронограф // Кардиология. – 2017. – Т. 57, № 10. – С. 39–44.
Caramori M. L., Fioretto P., Mauer M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? // Diabetes. – 2000. – Vol. 49, No. 9. – P. 1399–1408. – DOI: 10.2337/diabetes.49.9.1399.
Cederholm J., Eliasson B. et al. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients // Diabetes Research and Clinical Practice. – 2005. – No. 67. – P. 258–266.
Dalla Vestra M., Masiero A., Roiter A. M., Saller A., Crepaldi G., Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes // Diabetes. – 2003. – Vol. 52, No. 4. – P. 1031–1035. – DOI: 10.2337/diabetes. 52.4.1031.
Forouzanfar M. H., Liu P., Roth G. A., Ng M., Biryukov S., Marczak L., Alexander L., Estep K., Hassen Abate K., Akinyemiju T. F. et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015 // JAMA. – 2017. – Vol. 317, No. 2. – P. 165–182.
Granier C., Makni K., Molina L., Jardin-Watelet B., Ayadi H., Jarraya F. Gene and protein markers of diabetic nephropathy // Nephrology Dialysis Transplantation. – 2008. – Vol. 23, No. 3. – P. 792–799. – DOI: 10.1093/ndt/gfm834.
Gupta A., Nadim M. K. COVID-19 and the kidney: mechanism of injury and management // Kidney International Reports. – 2020. – Vol. 5, No. 12. – P. 2265–2273. – DOI: 10.1016/j.ekir.2020.09.013.
Jim B., Ghanta M., Qipo A., Fan Y., Chuang P. Y., Cohen H. W. et al. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross-sectional study // PLoS One. – 2012. – Vol. 7, No. 5. – P. e36041. – DOI: 10.1371/journal.pone.0036041.
Kopp J. B., Anders H. J., Susztak K., Podestà M. A., Remuzzi G., Hildebrandt F., Romagnani P. Podocytopathies // Nature Reviews Disease Primers. – 2020. – Vol. 6, No. 1. – P. 68. – DOI: 10.1038/s41572-020-0196-7.
Lastra G., Syed S., Kurukulasuriya L. R., Manrique C., Sowers J. R. Type 2 diabetes mellitus and hypertension: An update // Endocrinology and Metabolism Clinics of North America. – 2014. – Vol. 43, No. 1. – P. 103–122. – DOI: 10.1016/j.ecl.2013. 09.005.
Mills K. T., Stefanescu A., He J. The global epidemiology of hypertension // Nature Reviews Nephrology. – 2020. – Vol. 16, No. 4. – P. 223–237.
Nakatsue T., Koike H., Han G. D., Suzuki K., Miyauchi N., Yuan H. et al. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy // Kidney International. – 2005. – Vol. 67, No. 6. – P. 2239–2253. – DOI: 10.11 11/j.1523-1755.2005.00328.x.
Ng D. P., Tai B. C., Tan E., Leong H., Nurbaya S., Lim X. L. et al. Nephrinuria associates with multiple renal traits in type 2 diabetes // Nephrology Dialysis Transplantation. – 2011. – Vol. 26, No. 8. – P. 25 08–2514. – DOI: 10.1093/ndt/gfq738.
Petrie J. R., Guzik T. J., Touyz R. M. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms // Canadian Journal of Cardiology. – 2018. – Vol. 34, No. 5. – P. 575–584. – DOI: 10.1016/j.cjca.2017.12.005.
Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N. et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition // Diabetes Research and Clinical Practice. – 2019. – Vol. 157. – Article 107843.
Volpe M., Battistoni A., Savoia C., Tocci G. Understanding and treating hypertension in diabetic populations // Cardiovascular Diagnosis and Therapy. – 2015. – Vol. 5, No. 5. – P. 353–363. – DOI: 10.39 78/j.issn.2223-3652.2015.06.02.